EJMO. 2017; 1(2): 115-117 | DOI: 10.14744/ejmo.2017.10820
Sunitinib-Associated Acute Pancreatitis: A Case Report
Melek Karakurt Eryilmaz1
, Fatma Yalcin Musri1
, Derya Kivrak Salim1
, Gokhan Tazegul2
, Hasan Senol Coskun11
Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey, 2
Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey
Sunitinib is a multikinase inhibitor used for the treatment of metastatic renal cell carcinoma. Acute pancreatitis associated with sunitinib is rare. Presently described is a case of a 79-year-old man with metastatic renal cell carcinoma who developed acute pancreatitis following the initiation sunitinib treatment. The development of acute pancreatitis secondary to sunitinib should be considered in patients presenting with abdominal pain after the administration of sunitinib.
Cite This Article
Karakurt Eryilmaz M, Yalcin Musri F, Kivrak Salim D, Tazegul G, Coskun H. Sunitinib-Associated Acute Pancreatitis: A Case Report. EJMO. 2017; 1(2): 115-117
Corresponding Author: Karakurt Eryilmaz M.
Full Text PDF